CAS 388082-77-7
:ditosilato de lapatinibe
Descrição:
ditosilato de lapatinibe é um inibidor de tirosina quinase de pequenas moléculas usado principalmente no tratamento de certos tipos de câncer de mama, particularmente aqueles que são positivos para HER2. Funciona inibindo a atividade do receptor do fator de crescimento epidérmico (EGFR) e HER2, que estão envolvidos na proliferação e sobrevivência das células cancerosas. O composto é caracterizado por sua fórmula molecular, que reflete sua estrutura complexa, incluindo um grupo dicloroanilina e um grupo sulfonato que melhora sua solubilidade. ditosilato de lapatinibe é tipicamente administrado por via oral e é conhecido por sua capacidade de penetrar a barreira hematoencefálica, tornando-se uma opção potencial para o tratamento de metástases cerebrais. Sua farmacocinética inclui absorção moderada e uma meia-vida que permite a dosagem uma vez ao dia. Efeitos colaterais comuns podem incluir diarreia, erupção cutânea e náuseas. Assim como em qualquer terapia direcionada, seu uso é frequentemente acompanhado de monitoramento da eficácia e reações adversas, enfatizando a importância da medicina personalizada em oncologia.
Fórmula:C43H42ClFN4O10S3
InChI:InChI=1/C29H26ClFN4O4S.2C6H6O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*7-10(8,9)6-4-2-1-3-5-6;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*1-5H,(H,7,8,9);1H2
Chave InChI:InChIKey=OZDXXJABMOYNGY-UHFFFAOYSA-N
SMILES:N(C=1C2=C(C=CC(=C2)C=3OC(CNCCS(C)(=O)=O)=CC3)N=CN1)C4=CC(Cl)=C(OCC5=CC(F)=CC=C5)C=C4.S(=O)(=O)(O)C1=CC=C(C)C=C1
Sinónimos:- 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, 4-methylbenzenesulfonate (1:2)
- 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, bis(4-methylbenzenesulfonate)
- Benzenesulfonic Acid
- Gw 572016F
- Hydrate
- Lapatinib Ditoyslate
- Lapatinib ditosylate anhydrous
- Lapatinib, Tykerb, GW572016
- N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine bis(4-methylbenzenesulfonate)
- N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6 -[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine h ydrate
- N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
- N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine benzenesulfonate hydrate (1:2:1)
- N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine bis(4-methylbenzenesulfonate)
- Tykerb
- Tykerb N-{3-Chloro-4-[(3-fluorophenyl)-methoxy]-phenyl}-6-{5-{(2-methylsulfonylethy amino)-methyl]-2-furyl}-quinazolin-4-amine-benzenesulfonic acid
- Lapatinib ditosylate
- GW-572016 ditosylate
- Lapatinib (GW-572016) Ditosylate
- GW 572016 ditosylate
- N-{3-chloro-4-[(3-fluorobenzyl)oxyl]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine bis(4-methylBenzenesulfonate)
- Lapatinib Ditosylate (Tykerb)
- N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(Methylsulfonyl)ethyl]aMino}Methyl)-2-furyl]-4-quinazolinaMine 4-Methylbenzenesulfonate (1:2)
- GW-572016F Ditosylate
- Tykerb Ditosylat
- Lapatinib ditasylate
- N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,di4-methylbenzenesulfonate
- Tykerb(lapatinib)
- Tykerb Ditosylate
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 produtos.
Lapatinib Ditosylate
CAS:<p>Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).</p>Fórmula:C29H26ClFN4O4S·2C7H8O3SPureza:99.41%Cor e Forma:Yellow SolidPeso molecular:925.46Lapatinib Ditosylate
CAS:Fórmula:C29H26ClFN4O4S·2C7H8O3SCor e Forma:Yellow SolidPeso molecular:581.06 2*172.20Lapatinib-d4 Ditosylate
CAS:Fórmula:C29H22D4ClFN4O4S·2C7H8O3SCor e Forma:Light Yellow SolidPeso molecular:585.08 2 172.20N-(3-Chloro-4-((3-Fluorobenzyl)Oxy)Phenyl)-6-(5-(((2-(Methylsulfonyl)Ethyl)Amino)Methyl)Furan-2-Yl)Quinazolin-4-Amine Bis(4-Methylbenzenesulfonate)
CAS:N-(3-Chloro-4-((3-Fluorobenzyl)Oxy)Phenyl)-6-(5-(((2-(Methylsulfonyl)Ethyl)Amino)Methyl)Furan-2-Yl)Quinazolin-4-Amine Bis(4-Methylbenzenesulfonate)Pureza:98%Peso molecular:925.46g/molLapatinib Ditosylate
CAS:Fórmula:C29H26ClFN4O4S·2C7H8O3SPureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:925.46Lapatinib Ditosylate
CAS:Produto Controlado<p>Applications Reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic.<br>References Kim, T.E., et al.: Drugs, 6, 886 (2003), Wood, E.R., et al.: Cancer Res., 64, 6652 (2004), Spector, N.L., et al.: J. Clin. Oncol., 23, 2502 (2005),<br></p>Fórmula:C29H26ClFN4O4S·2C7H8O3SCor e Forma:YellowPeso molecular:925.46Lapatinib tosylate anhydrous
CAS:<p>Inhibitor of EGFR (ErbB1) and HER2 (ErbB2) receptor tyrosine kinases. Used for sensitization of HER2-overexpressing cancer cells to radiation as well as chemotherapy to tamoxifen- and trastuzumab-resistant cell lines. The compound blocks signalling via Akt and mitogen-activated protein kinase (MAPK) pathways leading to reduced cell survival. In trastuzumab resistant cancer cells, it inhibits HER2 phosphorylation, prevents receptor ubiquitination and causes accumulation of inactive HER2 dimers on the cell surface.</p>Fórmula:C29H26ClFN4O4S•(C7H8O3S)2Pureza:Min. 95%Cor e Forma:Off-White PowderPeso molecular:925.46 g/mol






